These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 9846813)
1. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis. Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813 [TBL] [Abstract][Full Text] [Related]
2. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis. Rohowsky-Kochan C; Molinaro D; Cook SD Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850 [TBL] [Abstract][Full Text] [Related]
3. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99). Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097 [TBL] [Abstract][Full Text] [Related]
4. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767 [TBL] [Abstract][Full Text] [Related]
5. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806 [TBL] [Abstract][Full Text] [Related]
6. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis. Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371 [TBL] [Abstract][Full Text] [Related]
7. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179 [TBL] [Abstract][Full Text] [Related]
8. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366 [TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Link J Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782 [TBL] [Abstract][Full Text] [Related]
10. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296 [TBL] [Abstract][Full Text] [Related]
11. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients. Takashima H; Smith DR; Fukaura H; Khoury SJ; Hafler DA; Weiner HL Clin Immunol Immunopathol; 1998 Jul; 88(1):28-34. PubMed ID: 9683547 [TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNgamma-producing effector cells. Calabresi PA; Yun SH; Allie R; Whartenby KA J Neuroimmunol; 2002 Jun; 127(1-2):96-105. PubMed ID: 12044980 [TBL] [Abstract][Full Text] [Related]
13. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes. Correale J; de los Milagros Bassani Molinas M J Neuroimmunol; 2003 Mar; 136(1-2):162-71. PubMed ID: 12620656 [TBL] [Abstract][Full Text] [Related]
14. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis. Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA Ann N Y Acad Sci; 1996 Feb; 778():251-7. PubMed ID: 8610978 [TBL] [Abstract][Full Text] [Related]
16. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Zang YC; Kozovska MM; Hong J; Li S; Mann S; Killian JM; Rivera VM; Zhang JZ Eur J Immunol; 1999 May; 29(5):1692-700. PubMed ID: 10359124 [TBL] [Abstract][Full Text] [Related]
17. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals. Hermans G; Stinissen P; Hauben L; Van den Berg-Loonen E; Raus J; Zhang J Ann Neurol; 1997 Jul; 42(1):18-27. PubMed ID: 9225681 [TBL] [Abstract][Full Text] [Related]
18. Glatiramer acetate (copolymer-1)-specific, human T cell lines: cytokine profile and suppression of T cell lines reactive against myelin basic protein. Dabbert D; Rösner S; Krämer M; Schöll U; Tumani H; Mäder M; Weber F Neurosci Lett; 2000 Aug; 289(3):205-8. PubMed ID: 10961665 [TBL] [Abstract][Full Text] [Related]
19. IL-12 induces human T cells secreting IL-10 with IFN-gamma. Windhagen A; Anderson DE; Carrizosa A; Williams RE; Hafler DA J Immunol; 1996 Aug; 157(3):1127-31. PubMed ID: 8757617 [TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]